244 related articles for article (PubMed ID: 25305591)
1. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Tan YV; Abad C; Wang Y; Lopez R; Waschek J
Brain Behav Immun; 2015 Feb; 44():167-175. PubMed ID: 25305591
[TBL] [Abstract][Full Text] [Related]
2. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis.
Tan YV; Abad C; Lopez R; Dong H; Liu S; Lee A; Gomariz RP; Leceta J; Waschek JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2012-7. PubMed ID: 19190179
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.
Tan YV; Abad C; Wang Y; Lopez R; Waschek JA
PLoS One; 2013; 8(4):e61200. PubMed ID: 23613811
[TBL] [Abstract][Full Text] [Related]
5. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.
Kato H; Ito A; Kawanokuchi J; Jin S; Mizuno T; Ojika K; Ueda R; Suzumura A
Mult Scler; 2004 Dec; 10(6):651-9. PubMed ID: 15584490
[TBL] [Abstract][Full Text] [Related]
7. PACAP/PAC1 Regulation of Inflammation via Catecholaminergic Neurons in a Model of Multiple Sclerosis.
Van C; Condro MC; Lov K; Zhu R; Ricaflanca PT; Ko HH; Diep AL; Hoang AQ; Pisegna J; Rohrer H; Waschek JA
J Mol Neurosci; 2019 Jul; 68(3):439-451. PubMed ID: 30058008
[TBL] [Abstract][Full Text] [Related]
8. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
10. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
11. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
Liu JQ; Liu Z; Zhang X; Shi Y; Talebian F; Carl JW; Yu C; Shi FD; Whitacre CC; Trgovcich J; Bai XF
J Immunol; 2012 Apr; 188(7):3099-106. PubMed ID: 22387555
[TBL] [Abstract][Full Text] [Related]
12. Impaired extinction of cued fear memory and abnormal dendritic morphology in the prelimbic and infralimbic cortices in VPAC2 receptor (VIPR2)-deficient mice.
Ago Y; Hayata-Takano A; Kawanai T; Yamauchi R; Takeuchi S; Cushman JD; Rajbhandari AK; Fanselow MS; Hashimoto H; Waschek JA
Neurobiol Learn Mem; 2017 Nov; 145():222-231. PubMed ID: 29030297
[TBL] [Abstract][Full Text] [Related]
13. PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice.
Hannibal J; Georg B; Fahrenkrug J
PLoS One; 2017; 12(11):e0188166. PubMed ID: 29155851
[TBL] [Abstract][Full Text] [Related]
14. Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity.
Wang LM; Zhang Y; Li X; Zhang ML; Zhu L; Zhang GX; Xu YM
Brain Behav Immun; 2018 Feb; 68():44-55. PubMed ID: 28962999
[TBL] [Abstract][Full Text] [Related]
15. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).
Huang MC; Miller AL; Wang W; Kong Y; Paul S; Goetzl EJ
J Immunol; 2006 Jun; 176(11):6640-6. PubMed ID: 16709822
[TBL] [Abstract][Full Text] [Related]
16. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
18. Impaired neonatal cardiorespiratory responses to hypoxia in mice lacking PAC1 or VPAC2 receptors.
Barrett KT; Hasan SU; Scantlebury MH; Wilson RJA
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R594-R606. PubMed ID: 30758978
[TBL] [Abstract][Full Text] [Related]
19. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.
Abad C; Tan YV; Lopez R; Nobuta H; Dong H; Phan P; Feng JM; Campagnoni AT; Waschek JA
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19555-60. PubMed ID: 20978211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
